• Lefevre M, Racedo SM, Ripert G, Housez B, Cazaubiel M, Maudet C, Jüsten P, Marteau P, Urdaci MC. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun Ageing. 2015. 12(24):1-11.

  • Spiller R, Pelerin F, Cayzeele Decherf A, Maudet C, Housez B, Cazaubiel M, Justen P. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterology Journal. 2015. 47(2):119–124.

  • Minami J, Kondo S, Yanagisawa N, Odamaki T, Xiao JZ, Abe F, Nakajima S, Hamamoto Y, Saitoh S, Shimoda T. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial.Journal of Nutritional Science. 2015. 4:e17.

  • Satoh T, Murata M, Iwabuchi N, Odamaki T, Wakabayashi H, Yamauchi K, Abe F, Xiao JZ. Effect of Bifidobacterium breve B-3 on skin photoaging induced by chronic UV irradiation in mice. Beneficial Microbes. 2015. 6(4):497-504.

  • Ansell J, Butts CA, Paturi G, Eady SL, Wallace AJ, Hedderley D, Gearry RB. Kiwifruit-derived supplements increase stool frequency in healthy adults: a randomized, double-blind, placebo-controlled study. Nutr Res. 2015. 401-408.

  • Lopresti AL, Maes M, Meddens MJ, Maker GL, Arnoldussen E, Drummond PD. Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change. Eur Neuropsychopharmacol. 2015. 25(1):38-50.

  • Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome. Dig Liver Dis. 2015 Feb;47(2):119-24.

  • Lehtoranta LM, Lehtinen MJ. Probiotici specifici per bambini e adulti contro il raffreddore comune. L’Integratore Nutrizionale. 2014. 17(4):16-23.

  • Lopresti A, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. Journal of Affective Disorders. 2014. 167: 368–375.

  • Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. 2014. 28:579–585

  • Cox AJ, West NP, Horn PL, Lehtinen MJ, Koerbin G, Pyne DB, Lahtinen SJ, Fricker PA, Cripps AW. Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults. European Journal of Clinical Nutrition. 2014. 1–3.

  • Giardina S, Scilironi C, Michelotti A, Samuele A, Borella F, Daglia M, Marzatico F. In vitro anti-Inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria. Journal of Food Science. 2014. 79(3): M384- M390.

  • Good M, Sodhi CP, Ozolek JA, Buck RH, Goehring KC, Thomas DL, Vikram A, Bibby K, Morowitz MJ, Firek B, Lu P, Hackam DJ. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. American Journal of Physiology and Gastrointestinal Liver Physiology. 2014. 306:G1021–G1032.

  • Morgan AR, Han DY, Wickens K, Barthow C, Mitchell EA, Stanley TV, Dekker J, Crane J, Ferguson LR. Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin Exp Allergy. 2014. 44(10):1255-1265.

  • Oda H, Wakabayashi H, Yamauchi K, Abe F. Lactoferrin and bifidobacteria. Biometals. 2014. 27:915–922.

  • Ouwehand AC,Lian CD, Weijian X, Stewart M, Ni J, Stewart T, Miller LE. Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study. Vaccine. 2014. 32:458– 463.

  • Patole S, Keil AD, Chang A, Nathan E, Doherty D, Simmer K, Esvaran M, Conway P. Effect of Bifidobacterium breve M-16V supplementation on fecal Bifidobacteria in preterm neonates – A randomised double blind placebo controlled trial. Plos One. 2014. 9(3):e89511(1-8).

  • Rastogi N, Nagpal N, Alam H, Pandey S, Gautam L, Sinha M, Shin K, Manzoor N, Virdi JS, Kaur P, Sharma S, Singh TP. Preparation and antimicrobial action of three tryptic digested functional molecules of bovine lactoferrin. Plos One. 2014. 9(3): e90011; pp. 1-12.

  • Ringel-Kulka T, Goldsmith JR, Carroll IM, Barros SP, Palsson O, Jobin C, Ringel Y. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain – a randomised clinical study. Alimentary Pharmacology & Therapeutics. 2014. 40:200–207.

  • Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, Goel A, Tripathi CB. Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial. Phytotherapy Research. 2014. 28:579–585.

  • Shakibaei M, Buhrmann C, Kraehe P, Shayan P, Lueders C, Goel A. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures. Plos One. 2014. 9(1):e85397(pp.1-12).

  • Wada Y, Lönnerdal B. Bioactive peptides derived from human milk proteins — mechanisms of action. Journal of Nutritional Biochemistry. 2014. 25:503–514.

  • West NP, Horn PL, Pyne DB, Gebski VJ, Lahtinen SJ, Fricker PA, Cripps AW. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.  Clinical Nutrition. 2014. 33(4):581-587.

  • Wakabayashi H, Oda H, Yamauchi K, Abe F. Lactoferrin for prevention of common viral infections. Journal of Infection and Chemotherapy. 2014. pp. 1-6 Article IN PRESS.

  • Kang EJ, Kim SY, Hwang IH, Ji YJ. The Effect of probiotics on prevention of common cold: a meta-analysis of randomized controlled trial studies. Korean Journal of Family Medicine. 2013. 34:2-10.

  • Ishizeki S, Sugita M, Takata M, Yaeshima T. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: A comparison between one-species and three-species administration. Anaerobe. 2013. 23:38-44.

  • Stahl B, Barrangou R. Complete Genome Sequence of Probiotic Strain Lactobacillus acidophilus La-14. Genome Announcement. 2013. 1(3): e00376-13.

  • Wen K, Li G, Bui T, Liu F, Li Y, Kocher J, Lin L, Yang X, Yuan L. High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine. 2012. 30(6):1198-207.

  • Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G, Siebers R, Black PN, Crane J. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clinical & Experimental Allergy. 2013. 43:1048–1057.

 

If you like to receive more scientific information about our ingredients, food supplements, medical devices and medical foods, please fill in the form